Healthcare

Healthcare and Life Sciences sector is comprised of businesses which have high levels of IP and technological know-how, mission-driven teams, and potential to become international champions. The rapid pace of change in some areas of technology and molecular biology lends it to entrepreneurial teams and investors like Inflexion.

Sector spotlight: Healthcare

Inflexion's Head of Healthcare Ben Long recently caught up with experienced healthcare executive Jane Griffiths about her long and successful career at J&J and the lessons she has learnt along the way. You can listen to the conversation here.

Play

Films

Play

Portfolio

CNX Therapeutics

Pharmaceuticals

In 2021 Inflexion acquired CNX Therapeutics, a UK-based pharmaceutical platform focused on providing life changing medicines. The business was formed when Inflexion acquired Sunovion Pharmaceuticals Europe’s operations. View case study

European LifeCare

Travel clinics

In 2018 Inflexion invested in European LifeCare, Europe's largest independent provider of travel clinics and public vaccination programmes. View case study

HKI

Healthcare information services

In 2004 Inflexion acquired public health performance analytics business HKI in a £10m deal. The business was later sold in two parts for an overall return of 2.6x. View case study

ICS

Temporary staffing solutions

Temporary healthcare staffing business ICS chose to partner with Inflexion in 2008. It was sold 22 months later to Blackstone Group for an overall return on investment of 2.9x. View case study

Lintbells

Supplements for pets

In 2017, Inflexion invested in Lintbells, the UK’s leading producer of nutritional supplements for pets. View case study

Medivet

Veterinary services

In 2016, Inflexion provided minority funding to support the expansion of Medivet, a UK veterinary pet-care business. A successful partnership delivered strong acquisitive and organic growth, and Medivet was sold in 2021 to CVC Capital Partners. View case study

Pharmaspectra

Medical affairs data

In 2019, Inflexion invested in Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. Inflexion exited the business in 2022. View case study

Phlexglobal

Clinical research documentation management

Inflexion backed the buyout of TMF services provider Phlexglobal in 2011, supporting its growth until it was sold to Bridgepoint Development Capital in 2014. View case study

Proteros

Drug discovery research platform

Proteros Biostructures GmbH, a leading German-based, founder-led contract research organisation focused on early-stage drug discovery. View case study

Rosemont Pharmaceuticals

Liquid pharmaceuticals

In 2020 Inflexion acquired Rosemont Pharmaceuticals, the UK’s leading liquid pharmaceuticals business. The business was carved out of listed parent company, Perrigo. View case study

SteriPack

Medical device contract designer and manufacturer

SteriPack is a leading global contract manufacturer serving the medical device, pharmaceutical and diagnostic markets. Inflexion led the buyout of SteriPack in 2022. View case study

Upperton Pharma Solutions

Particle engineering for the pharmaceutical industry

In 2022, Inflexion made a substantial investment into Upperton Pharma Solutions, a UK based specialist contract development and manufacturing organisation which has expertise in particle engineering for the pharmaceutical industry. View case study

Team

Ben Long

Partner

Ben is a Partner and head of the Healthcare sector at Inflexion. Read biography

Andrew Neville

Investment Director

Andrew is an Investment Director responsible for appraising and executing majority and minority investments as well as originating new mid-market opportunities, with a focus on the healthcare sector. Read biography

Rob Dagger

Investment Director

Rob is an Investment Director responsible for originating, evaluating and executing transactions. Read biography

Sam McPhail

Assistant Director

Sam is an Assistant Director responsible for evaluating and executing transactions, as well as supporting the origination of investment opportunities. Read biography

Saloshnee Nightingale

Assistant Director

Saloshnee is an Assistant Director responsible for transaction execution as well as supporting the origination of majority and minority investment opportunities. Read biography

Robin Senivassen

Investment Director

Robin is an Investment Director responsible for transaction execution and supporting the origination of investment opportunities in the lower mid-market. Read biography

Ravi Shah

Investment Director

Ravi is an Investment Director responsible for evaluating and executing transactions. Read biography

Marcus Ward

Assistant Director

Marcus is an Assistant Director responsible for evaluating and executing transactions, and supporting the origination of investment opportunities. Read biography

Christian Fellowes

Investment Director

Christian is an Investment Director on the Healthcare team and brings a combination of medical, transaction and entrepreneurial experience to Inflexion. Read biography